Clinical trials
Neurofibromatoses trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2004 | 2 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 7 |
| 2014 | 3 |
| 2015 | 2 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 32 |
| Recruiting | 10 |
| Terminated | 5 |
| Unknown status | 3 |
| Not yet recruiting | 3 |
| Active, not recruiting | 2 |
| Suspended | 1 |
| Available | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Massachusetts General Hospital | 8 |
| National Cancer Institute (NCI) | 5 |
| Indiana University | 3 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2 |
| Johns Hopkins University | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 2 |
| SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany | 2 |
| University of Alabama at Birmingham | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neurofibromatoses | 57 |
| Neurofibromatosis 1 | 23 |
| Neurofibroma, Plexiform | 10 |
| Neurofibroma | 9 |
| Neurofibromatosis 2 | 7 |
| Neoplasms | 3 |
| Neurofibrosarcoma | 3 |
| Neuroma, Acoustic | 3 |
| Tuberous Sclerosis | 3 |
| Anemia, Sickle Cell | 2 |
Trials
Showing 26 to 50 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.